**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 87-62-7 |2,6-Dimethylaniline | 99 | 201-758-7 |
|----------------|--------------------------------------|----------|-----------|
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XN N
Risk Phrases: 20/21/22 37/38 40 51/53
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to respiratory system and skin. Limited evidence of a
carcinogenic effect. Toxic to aquatic organisms, may cause long-term
adverse effects in the aquatic environment.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
Causes gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause methemoglobinemia, cyanosis (bluish discoloration
of skin due to deficient oxygenation of the blood), convulsions, and
death. Methemoglobinemia is characterized by dizziness, drowsiness,
headache, shortness of breath, cyanosis (bluish discoloration of
skin due to deficient oxygenation of the blood), rapid heart rate and
chocolate-brown colored blood. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May cause methemoglobinemia,
cyanosis (bluish discoloration of skin due to deficient oxygenation
of the blood), convulsions, tachycardia, dyspnea (labored
breathing), and death. Methemoglobinemia is characterized by
dizziness, drowsiness, headache, shortness of breath, cyanosis
(bluish discoloration of skin due to deficient oxygenation of the
blood), rapid heart rate and chocolate-brown blood. May be harmful
if inhaled.
Chronic:
Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Combustible liquid and vapor.
Extinguishing Media:
Water or foam may cause frothing. Water may be ineffective. Use
water fog, dry chemical, carbon dioxide, or regular foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Provide ventilation. A vapor
suppressing foam may be used to reduce vapors. Approach spill from
upwind. Control runoff and isolate discharged material for proper
disposal.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Avoid contact
with eyes, skin, and clothing. Avoid ingestion and inhalation.
Storage:
Keep away from sources of ignition. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances. Separate from acids, oxidizing materials,
and hypochlorite mixtures.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 87-62-7:
CAS# 1300-73-8:
United States OSHA: 5 ppm TWA; 25 mg/m3 TWA
Belgium - TWA: 0.5 ppm VLE; 2.5 mg/m3 VLE
France - VME: 2 ppm VME; 10 mg/m3 VME
Germany: 5 ppm TWA; 25 mg/m3 TWA
Germany: Skin absorber
Malaysia: 0.5 ppm TWA; 2.5 mg/m3 TWA
Netherlands: 0.5 ppm MAC; 2.5 mg/m3 MAC
Russia: 3 mg/m3 TWA
Spain: 0.5 ppm VLA-ED; 2.5 mg/m3 VLA-ED
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: colorless to yellow-red
Odor: None reported.
pH: Not available.
Vapor Pressure: 0.125 mm Hg @ 20 C
Viscosity: Not available.
Boiling Point: 216 deg C @ 760mm Hg
Freezing/Melting Point: 10 - 12 deg C
Autoignition Temperature: 490 deg C ( 914.00 deg F)
Flash Point: 91 deg C ( 195.80 deg F)
Explosion Limits, lower: 1.30 vol %
Explosion Limits, upper: 6.90 vol %
Decomposition Temperature: >350 deg C
Solubility in water: Slightly soluble.
Specific Gravity/Density: .9800g/cm3
Molecular Formula: C8H11N
Molecular Weight: 121.18
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Ignition sources, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, acids, acid chlorides, halogens, acid
anhydrides, hypochlorite, chloroformates.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 87-62-7: ZE9275000
CAS# 1300-73-8: ZE8575000
LD50/LC50:
CAS# 87-62-7: Oral, mouse: LD50 = 707 mg/kg; Oral, rat: LD50 = 840
mg/kg.
CAS# 1300-73-8: Oral, rabbit: LD50 = 600 mg/kg; Skin, rabbit: LD50 =
1500 mg/kg; Skin, rat: LD50 = 2 gm/kg.
Carcinogenicity:
2,6-Dimethylaniline -
California: carcinogen, initial date 1/1/91
IARC: Group 2B carcinogen
Xylidine (mixed isomers) -
ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: XYLIDINES
Hazard Class: 6.1
UN Number: 1711
Packing Group: II
IMO
Shipping Name: XYLIDINES, LIQUID or SOLID
Hazard Class: 6.1
UN Number: 1711
Packing Group: II
RID/ADR
Shipping Name: XYLIDINES
Hazard Class: 6.1
UN Number: 1711
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN N
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 37/38 Irritating to respiratory system and skin.
R 40 Limited evidence of a carcinogenic effect.
R 51/53 Toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
Safety Phrases:
S 23 Do not inhale gas/fumes/vapour/spray.
S 25 Avoid contact with eyes.
S 36/37 Wear suitable protective clothing and
gloves.
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 87-62-7: 2
CAS# 1300-73-8: No information available.
Canada
CAS# 87-62-7 is listed on Canada's DSL List.
CAS# 1300-73-8 is listed on Canada's NDSL List.
CAS# 87-62-7 is not listed on Canada's Ingredient Disclosure List.
CAS# 1300-73-8 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 87-62-7 is listed on the TSCA inventory.
CAS# 1300-73-8 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 4/17/1998 Revision #3 Date: 6/28/2002
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-Methylcyclopropanecarboxylic Acid, 98%
| 29555-02-0 |
|
m-Phenylene diisocyanate
| 123-61-5 |
|
2-Dodecanol, 99%
| 10203-28-8 |
|
Oxalic Acid Bis(Benzylidenehydrazide), 97% (UV-Vis)
| 6629-10-3 |
|
5-Bromopyrimidine, 98%
| 4595-59-9 |
|
4,6-Diamino-2-Mercaptopyrimidine, Hemihydrate, 99%
| 1004-39-3 |
|
4-(4'-Aminophenylazo)-Phenylarsonic Acid
| 6966-64-9 |
|
2,4-Dicyano-3-Methylglutaramide, 99%
| 5447-66-5 |
|
Ethyl trimethylacetate, 98%
| 3938-95-2 |
|
2-Mercapto-4-methylpyrimidine hydrochloride, 99%
| 6959-66-6 |
|
1-Pyrrolidinecarboxaldehyde, 97%
| 3760-54-1 |
|
n-Methyleneglycinonitrile (trimer)
| 6865-92-5 |
|
5-Methoxytryptamine hydrochloride, 97%
| 66-83-1 |
|
Nifuroxime
| 555-15-7 |
|
N-Alpha-Acetyl-L-Histidine Monohydrate 99+%
| 39145-52-3 |
|
11-Bromoundecanoic acid, tech., 93%
| 2834-05-1 |
|
Tert.-Butyl Disulfide, 98%
| 110-06-5 |
|
4'-Dodecyloxyacetophenone, 94% (GC)
| 2175-80-6 |
|
Ethylmagnesium chloride, 25 wt% solution in tetrahydrofuran
| 109-99-9 |
|
Methyl Vinyl Ether/Maleic Acid Copolymer, Low Molecular Weight
| 25153-40-6 |
|
Chlorohydroquinone, tech., 90%
| 615-67-8 |
|
Tri-n-octylphosphine oxide, 97%
| 78-50-2 |
|
Silver proteinate (mild)
| 9008-42-8 |
|
Lead (IV) Oxide, P.A.
| 1309-60-0 |
|
1,4-Butane Sultone, 99+%
| 1633-83-6 |
|
4-Chloro-3-Iodobenzotrifluoride, 99%
| 672-57-1 |
|
Theophylline, Anhydrous, U.S.P./N.F.
| 58-55-9 |
|
P-Anisoyl Chloride, 99%
| 100-07-2 |
|
3-Carboxy-1,4-dimethyl-1h-pyrrole-2-acetic acid
| 33369-45-8 |
|
4-Amino-2,6-dichlorophenol, 98%
| 5930-28-9 |
|
Aminoguanidine Hemisulfate
| 996-19-0 |
|
N-Methylmorpholine hydrochloride, 99+%
| 3651-67-0 |
|
2-Chloro-4,6-dimethoxy-1,3,5-triazine, 98%
| 3140-73-6 |
|
1-Heptyne, 99%
| 628-71-7 |
|
(R)-(+)-2,2'-Bis(diphenylphosphino)- 1,1'-binaphthyl, 99+%
| 76189-55-4 |
|
2-Propene-1-Sulfonic Acid Sodium Salt (Pract)
| 2495-39-8 |
|
6-Amino-1-Hexanol, 94%
| 4048-33-3 |
|
2,5-Dibromonitrobenzene, 97%
| 3460-18-2 |
|
Rubidium Fluoride Hydrate, 99+%
| 16422-67-6 |
|
7-Chloro-2H-1,4-Benzothiazin-3(4H)-One,99%
| 5333-05-1 |
|
2-Methyl-2-Nitropropane, 99%
| 594-70-7 |
|
N-Ethyl-n-butylamine, 99%
| 13360-63-9 |
|
2,6-Dimethylaniline, 99%
| 87-62-7 |
|
2-Chloro-3-Methylquinoline, 97%
| 57876-69-4 |
|
3-Cyanobenzaldehyde, 99%
| 24964-64-5 |
|
N,N'-Diallyltartardiamide, 99+%
| 28843-34-7 |
|
3-Aminobenzonitrile, 99%
| 2237-30-1 |
|
2-Chloropyridine-n-oxide hydrochloride, 97%
| 20295-64-1 |
|
Sodium perchlorate
| 7601-89-0 |
|
Butadiene sulfone, 98%
| 77-79-2 |
|
|